LigoCyte Buyout Beats Odds; Viral 'Load' on the Front End
It was an unlikely project, all the way around.
First, getting together a syndicate of venture capital investors to bet on vaccines – medicines typically given to healthy subjects, which makes possible toxicity an especially dicey proposition.
"You cannot have a safety problem, or you're dead," said Ivor Royston, founding managing partner of Forward Ventures, apparently intending no pun. "Why would a venture capitalist invest in something like that?"
Suite: 1100 | Atlanta, Georgia 30346, USA
In the U.S. and Canada: 1-800-477-6307
Outside the U.S.: 1-770-810-3144
In the U.S. and Canada: 1-800-336-4474
Outside the U.S.: 1-215-386-0100
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST
Sign up for Perspectives FREE e-mail newsletter